医学
支气管胸膜瘘
杜瓦卢马布
放化疗
外科
抢救性手术
瘘管
肺癌
肺炎
全肺切除术
挽救疗法
放射治疗
肺
癌症
化疗
内科学
无容量
免疫疗法
作者
Makoto Tada,Hirofumi Uehara,Takeshi Ohyu,Atsushi Watanabe
标识
DOI:10.1016/j.athoracsur.2021.11.063
摘要
Herein we describe a case of salvage lobectomy for a bronchopleural fistula secondary to durvalumab after chemoradiotherapy in initially unresectable non-small cell lung cancer. A 75-year-old man with adenocarcinoma, c-stage IIIB (T4N2M0) in the upper lobe of the right lung, received durvalumab after chemoradiotherapy. Fourteen months after durvalumab was discontinued, pneumonitis developed followed by peripheral bronchopleural fistula, and he unavoidably underwent salvage right upper lobectomy. The postoperative course was uneventful, and air leakage ceased. After chemoradiotherapy and durvalumab, refractory air leakage may develop that may require salvage surgery.
科研通智能强力驱动
Strongly Powered by AbleSci AI